Bennett Willard, DO
Interventional Pain Medicine · Grand Rapids, MINPI 1134186513
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $627 and has fallen 94.7% since, to $33 in 2024. That places this record below the midpoint for interventional pain medicine clinicians in MI, where the typical reported total is $2,071.
Across 65 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$204
- Supernus Pharmaceuticals, Inc.$100
- Abbott$100
- Assertio Therapeutics, Inc.$98
- AbbVie$80
- Novartis$73
- plus $457 from 12 others
What the payments were for
- Food & beverage$1,112100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $204 |
| Supernus Pharmaceuticals, Inc. | 5 | $100 |
| Abbott | 4 | $100 |
| Assertio Therapeutics, Inc. | 6 | $98 |
| AbbVie(2 entities) | 5 | $80 |
| Novartis | 4 | $73 |
| Collegium Pharmaceutical, Inc. | 4 | $64 |
| Vertiflex, Inc. | 1 | $58 |
| Lilly USA, LLC | 4 | $56 |
| Pfizer | 3 | $52 |
| Medtronic | 3 | $44 |
| Boston Scientific | 2 | $41 |
| Amgen | 2 | $36 |
| Nevro Corp. | 1 | $27 |
| Johnson & Johnson | 2 | $26 |
| GRT US Holding, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
How this compares
$1,112 in reported general payments places this provider in the 40th percentile of 88 interventional pain medicine providers in Michigan.
See all interventional pain medicine providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 355 | $7,835 |
| Fentanyl | 38 | $3,772 |
| Gabapentin | 151 | $2,325 |
| Morphine Sulfate ErMorphine Sulfate | 46 | $1,208 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 50 | $1,157 |
| Naloxone Hcl | 15 | $1,081 |
| Pregabalin | 31 | $701 |
| Baclofen | 44 | $660 |
| Methadone Hcl | 36 | $623 |
| Oxycodone Hcl | 30 | $502 |
| Diclofenac Sodium | 18 | $439 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 18 | $407 |
| Levetiracetam | 22 | $362 |
| Tizanidine Hcl | 31 | $332 |
| Tramadol Hcl | 59 | $319 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Grand Rapids
- Mary LeemputteGrand Rapids$8K
- Keith JaveryGrand Rapids$3K
- Marc KornGrand Rapids$3K
- Stephen WinstonGrand Rapids$2K
- Scott GreenwaldGrand Rapids$2K
- Daniel MankoffGrand Rapids$1K
- Ryan PollinaSaint Clair Shores$144K
- Ariel MajjhooMonroe$124K
- Chad BrummettAnn Arbor$109K
- Anand ThakurClinton Township$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.